×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
THAR – tharimmune, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
THAR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/16
08:27 am
thar
Tharimmune Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis and Provides a Business Update [Yahoo! Finance]
Low
Report
Tharimmune Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis and Provides a Business Update [Yahoo! Finance]
12/16
08:00 am
thar
Tharimmune Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis and Provides a Business Update
Low
Report
Tharimmune Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis and Provides a Business Update
12/10
07:32 am
thar
Tharimmune, Inc. (NASDAQ: THAR) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
Medium
Report
Tharimmune, Inc. (NASDAQ: THAR) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
12/6
04:35 pm
thar
Tharimmune Announces $2.02 Million Private Placement to Advance Development Programs [Yahoo! Finance]
High
Report
Tharimmune Announces $2.02 Million Private Placement to Advance Development Programs [Yahoo! Finance]
12/6
04:15 pm
thar
Tharimmune Announces $2.02 Million Private Placement to Advance Development Programs
Medium
Report
Tharimmune Announces $2.02 Million Private Placement to Advance Development Programs
12/6
02:49 pm
thar
Tharimmune, Inc. (NASDAQ: THAR) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $17.00 price target on the stock.
Low
Report
Tharimmune, Inc. (NASDAQ: THAR) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $17.00 price target on the stock.
11/18
08:22 am
thar
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease [Yahoo! Finance]
High
Report
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease [Yahoo! Finance]
11/18
08:00 am
thar
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
Medium
Report
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/20
08:01 pm
thar
Form 4 Tharimmune, Inc. For: Dec 19 Filed by: MILBY RANDY
Low
Report
Form 4 Tharimmune, Inc. For: Dec 19 Filed by: MILBY RANDY
12/6
05:26 pm
thar
Form 8-K Tharimmune, Inc. For: Dec 05
High
Report
Form 8-K Tharimmune, Inc. For: Dec 05
12/2
04:00 pm
thar
Form 3 Tharimmune, Inc. For: Nov 20 Filed by: Parikh Sanam
Low
Report
Form 3 Tharimmune, Inc. For: Nov 20 Filed by: Parikh Sanam
11/21
04:52 pm
thar
Form 8-K Tharimmune, Inc. For: Nov 20
Low
Report
Form 8-K Tharimmune, Inc. For: Nov 20
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: